|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1989-5-5
|
|
pubmed:abstractText |
Eleven patients with acute myeloid leukaemia have been transplanted with autologous marrow grown in long-term bone marrow culture. In the high risk group (six patients who had all previously relapsed) the procedure induced a remission in two patients who were in florid relapse at the time of the transplant. Five patients were transplanted in first remission and they remain well and disease-free between 150 and 12 weeks after their autologous transplant.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0268-3369
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:2647188-Adolescent,
pubmed-meshheading:2647188-Adult,
pubmed-meshheading:2647188-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:2647188-Bone Marrow Transplantation,
pubmed-meshheading:2647188-Cells, Cultured,
pubmed-meshheading:2647188-Combined Modality Therapy,
pubmed-meshheading:2647188-Cytarabine,
pubmed-meshheading:2647188-Daunorubicin,
pubmed-meshheading:2647188-Humans,
pubmed-meshheading:2647188-Leukemia, Myeloid, Acute,
pubmed-meshheading:2647188-Pilot Projects,
pubmed-meshheading:2647188-Remission Induction,
pubmed-meshheading:2647188-Risk,
pubmed-meshheading:2647188-Thioguanine,
pubmed-meshheading:2647188-Transplantation, Autologous
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update.
|
|
pubmed:affiliation |
Department of Experimental Haematology, Paterson Institute, Christie Hospital, Manchester, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
